is predominantly active in the CNS area; however our portfolio also consists of antiemetic, anti-infective, cardiovascular, pain and respiratory products.
Lesvi is driven by Research and Development which is reflected in the NUMBER OF PRODUCTS SUPPLIED AND DISTRIBUTED
all over the world and in the loyalty of our clients
MOLECULES IN CNS
>270 inventions generating >1.200 patents worldwideMORE
Lesvi is part of Neuraxpharm, a leading European specialty pharmaceutical company in the treatment of central nervous system disorders (CNS).
Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals and nutraceuticals related to the prevention of CNS indications.
Additionally, through its manufacturing companies Lesvi and Inke, Neuraxpharm has an international presence in over 50 countries. It provides industry partners with finished dosage forms (FDFs) across multiple technologies and niche active pharmaceutical ingredients (APIs).
Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.
© Neuraxpharm / LESVI. All rights reserved.